Mo et al. [50] described that 1/73 (1%) regionally localized PCs (RLPCs) and 0/7 (0%) CRPCs expressed PD-L1 on tumor cells; 69/73 (94.5%) RLPCs and 2/7 CRPCs were positive for PD-L1 in the tumor-associated stroma (nerve branches), supported by co-localization with axonal marker PGP9.5. The gene discussed is CD274; the disease is neoplasm.